Main Page: Difference between revisions
(9 intermediate revisions by the same user not shown) | |||
Line 52: | Line 52: | ||
| 1.21|| [[Freestanding ED Transport Criteria]]|| April-23 || | | 1.21|| [[Freestanding ED Transport Criteria]]|| April-23 || | ||
|- | |- | ||
| 1.22|| [[Hospital Capability Chart - DRAFT|Hospital Capability Chart]]|| | | 1.22|| [[Hospital Capability Chart - DRAFT|Hospital Capability Chart]]|| May-24 ||May-24 | ||
|- | |- | ||
| 1.23|| [[Documentation Guidance]]|| June- | | 1.23|| [[Documentation Guidance]]|| June-24 ||June-24 | ||
|- | |- | ||
| 1.24|| [[School Medication Authorization Forms]]|| June-18 || | | 1.24|| [[School Medication Authorization Forms]]|| June-18 || | ||
|} | |} | ||
Line 111: | Line 112: | ||
|4.05||[[Premature Ventricular Contractions (PVC)]]||May-12 | |4.05||[[Premature Ventricular Contractions (PVC)]]||May-12 | ||
|- | |- | ||
|4.06||[[Supraventricular Bradycardia and AV Blocks]]|| | |4.06||[[Supraventricular Bradycardia and AV Blocks]]||April-24 | ||
|- | |- | ||
|4.07||[[Supraventricular Tachycardia]]||January-20 | |4.07||[[Supraventricular Tachycardia]]||January-20 | ||
Line 142: | Line 143: | ||
|5.03||[[Altered Mental Status (AMS)]]||April-17 | |5.03||[[Altered Mental Status (AMS)]]||April-17 | ||
|- | |- | ||
|5.04||[[Suspected Stroke Transcient Ischemic Attack TIA|Suspected Stroke or Transcient Ischemic Attack]]|| | |5.04||[[Suspected Stroke Transcient Ischemic Attack TIA|Suspected Stroke or Transcient Ischemic Attack]]||May-24 | ||
|- | |- | ||
|5.05||[[Drug Overdose Poisoning]]||March-09 | |5.05||[[Drug Overdose Poisoning]]||March-09 | ||
Line 197: | Line 198: | ||
|6.05||[[Decompression Sickness or Dysbarism]]||March-09 | |6.05||[[Decompression Sickness or Dysbarism]]||March-09 | ||
|- | |- | ||
|6.06||[[Extremity Injuries]]|| | |6.06||[[Extremity Injuries]]||January-24 | ||
|- | |- | ||
|6.07||[[Head Injuries]]||January-24 | |6.07||[[Head Injuries]]||January-24 | ||
Line 209: | Line 210: | ||
|6.11||[[Suspected Sexual Assault]]||March-09 | |6.11||[[Suspected Sexual Assault]]||March-09 | ||
|- | |- | ||
|6.12||[[Trunk Penetrating Injuries]]|| | |6.12||[[Trunk Penetrating Injuries]]||January-24 | ||
|- | |- | ||
|6.13||[[Hemorrhagic Shock]]||October-18 | |6.13||[[Hemorrhagic Shock]]||October-18 | ||
Line 439: | Line 440: | ||
|- | |- | ||
|9.40||[[T-POD Pelvic Stabilization Device]]||Sept-23 | |9.40||[[T-POD Pelvic Stabilization Device]]||Sept-23 | ||
|- | |||
|9.41||[[Controlled Substance Disposal Procedures]]||Mar-24 | |||
|} | |} | ||
Revision as of 15:38, 12 July 2024
TABLE OF CONTENTS
Medical Director Authorization
Section 1 - Administrative Policies
Section 2 - Primary Care
Section | Description | Revision Date |
---|---|---|
2.01 | Initial Medical Assessment and Care | March-09 |
2.02 | Initial Trauma Assessment and Care | September-17 |
2.03 | Rapid Trauma Assessment, Focused History and Physical Exam | Sept-15 |
2.04 | Analgesia and Sedation | December-20 |
2.05 | Drug Assisted Intubation | December-16 |
Section 3 - Respiratory
Section | Description | Revision Date |
---|---|---|
3.01 | Acute Asthma or COPD with Wheezing | February-19 |
3.02 | Carbon Monoxide Inhalation | June-19 |
3.03 | Foreign Body Airway Obstruction | March-09 |
3.04 | Infectious Upper Airway Obstruction - Croup or Epiglottitis | April-16 |
3.05 | Severe Respiratory Pathogens | November-10 |
3.06 | Anxiety or Hyperventilation | February-11 |
Section 4 - Cardiac
Section | Description | Revision Date |
---|---|---|
4.01 | Chest Pain Acute Coronary Syndrome | Mar-22 |
4.02 | Asystole | December-22 |
4.03 | Atrial Fibrillation Atrial Flutter | April-20 |
4.04 | Pulseless Electrical Activity (PEA) | January-16 |
4.05 | Premature Ventricular Contractions (PVC) | May-12 |
4.06 | Supraventricular Bradycardia and AV Blocks | April-24 |
4.07 | Supraventricular Tachycardia | January-20 |
4.08 | Ventricular Fibrillation Pulseless Ventricular Tachycardia | December-16 |
4.09 | Ventricular Tachycardia with a Palpable Pulse | July-12 |
4.10 | Wide Complex Tachycardia Uncertain Origin | January-20 |
4.11 | Acute Cardiogenic Pulmonary Edema Pneumonia | March-09 |
4.12 | Code Cool Post ROSC Induced Hypothermia | March-09 |
4.13 | Adult Immediate Post-Cardiac Arrest Care | April-12 |
4.14 | Ventricular Assist Devices | March-22 |
Section 5 - Medical
Section | Description | Revision Date |
---|---|---|
5.01 | Acute Abdominal Pain | April-16 |
5.02 | Allergic Reaction Anaphylactic Shock | March-19 |
5.03 | Altered Mental Status (AMS) | April-17 |
5.04 | Suspected Stroke or Transcient Ischemic Attack | May-24 |
5.05 | Drug Overdose Poisoning | March-09 |
5.06 | Cold Emergencies | April-12 |
5.07 | Heat Emergencies | August-15 |
5.08 | Hazardous Materials | July-22 |
5.09 | Severe Hypertension | March-09 |
5.10 | Hypo or Hyperglycemia | April-16 |
5.11 | Psychological Behavioral Emergencies | March-09 |
5.12 | Seizure | April-16 |
5.13 | Non-Hemorrhagic Shock | October-18 |
5.14 | Sickle Cell Anemia Crisis | March-09 |
5.15 | Syncope | March-09 |
5.16 | Vertigo | March-09 |
5.17 | Sepsis Septic Shock | Jan-24 |
5.18 | Suspected Kidney Stone | April-16 |
5.19 | Cyanide Poisoning | April-16 |
5.20 | Excited Delirium or Drug Induced Agitation | November-17 |
5.21 | Ebola Virus Disease Patient Management | October-14 |
5.22 | Acute Adrenal Insufficiency | June-18 |
Section 6 - Trauma
Section | Description | Revision Date |
---|---|---|
6.01 | Animal Bites Stings | August-18 |
6.02 | Burns - Thermal, Electrical, Chemical | March-09 |
6.03 | Selective Spinal Immobilization | August-14 |
6.04 | Chest Injuries | March-09 |
6.05 | Decompression Sickness or Dysbarism | March-09 |
6.06 | Extremity Injuries | January-24 |
6.07 | Head Injuries | January-24 |
6.08 | Near Drowning | March-09 |
6.09 | Ophthalmic Injuries | March-09 |
6.10 | Suspected Abuse Neglect | March-09 |
6.11 | Suspected Sexual Assault | March-09 |
6.12 | Trunk Penetrating Injuries | January-24 |
6.13 | Hemorrhagic Shock | October-18 |
Section 7 - Pediatric and Obstetrical
Section | Description | Revision Date |
---|---|---|
7.01 | Pediatric Asystole | April-16 |
7.02 | Pediatric Pulseless Electrical Activity PEA | April-16 |
7.03 | Pediatric Ventricular Fibrillation or Pulseless Ventricular Tachycardia | April-16 |
7.04 | Pregnancy Induced Hypertension (PIH) | April-20 |
7.05 | Preterm Labor | November-17 |
7.06 | Emergency Childbirth | November-17 |
7.07 | Childbirth Complications | November-17 |
7.08 | Newborn Care | April-16 |
7.09 | Post Partum Care | November-17 |
7.10 | Pediatric Febrile Emergency | April-16 |
7.11 | Vaginal Bleeding | March-09 |
7.12 | Trauma In Pregnancy | March-09 |
Section 8 - Medication Guidelines
INTRODUCTION The following pages contain guidelines for the medications commonly encountered by the Paramedic. They identify the name and class of the drug, a short description, indications, contraindications, precautions, and dosages. This is only a guideline to medication administration and shall not circumvent the need to refer to the appropriate Standing Order or to contact Medical Control for orders and consultation. For detailed and extensive information on each drug, refer to the Physician's Desk Reference, the Advanced Cardiac Life Support text or an emergency pre-hospital pharmacology reference.
Certain medications listed have various dosages depending on the patient's condition. Refer to the appropriate Standing Order or contact Medical Control for specific dosage information. All IV piggyback medications must be placed on a micro-gtt. solution set for field administration and if available, an infusion pump or infusion regulator MUST BE UTILIZED.
The following medications are authorized to be administered by Seminole County EMS:
Medication Name | Revision Date |
---|---|
Acetaminophen | March-09 |
Adenosine | January-20 |
Albuterol | April-16 |
Amiodarone | July-17 |
Ancef | January-24 |
Aspirin | March-09 |
Atropine | July-17 |
Atrovent | April-16 |
Calcium Chloride | April-16 |
Cardizem | July-17 |
Cyanokit | April-16 |
Dextrose 10% | April-16 |
Dextrose 50% | April-16 |
Diphenhydramine | April-16 |
Dopamine | April-16 |
Epinephrine | April-16 |
Flumazenil | April-16 |
Geodon | April-16 |
Glucagon | April-16 |
Hypertonic Saline | January-24 |
Keppra | January-24 |
Ketamine | November-20 |
Lasix | April-16 |
Lidocaine | July-17 |
Magnesium Sulfate | April-16 |
Morphine Sulfate | November-16 |
Naloxone | April-16 |
Nitro Drip | April-17 |
Nitro Spray | April-17 |
Nitro Tablets | April-17 |
Nitrous Oxide | November-16 |
Oxygen | March-09 |
Pepcid | April-16 |
Pontocaine | November-17 |
Promethazine | April-16 |
Racemic Epinephrine | April-16 |
Sodium Bicarbonate | April-16 |
Solu-Medrol | January-17 |
Toradol | March-09 |
TXA | October-20 |
Xopenex | April-16 |
Valium | April-16 |
Versed | April-16 |
Zofran | April-16 |
Medication Infusion Tables | March-09 |
Section 9 - Procedure Guidelines
Section 10 - References
Section | Description | Revision Date |
---|---|---|
10.01 | Abbreviations | March-09 |
10.02 | Apgar Score | March-09 |
10.03 | Glasgow Coma Score | March-09 |
10.04 | Pediatric Vital Signs | March-09 |
10.05 | Adult Trauma Alert Criteria | March-09 |
10.06 | Pediatric Trauma Alert Criteria | March-09 |
10.07 | Pediatric Trauma Score | March-09 |
10.08 | Nitroglycerin Drip | March-09 |
10.09 | Checking Range of Motion | March-09 |
10.10 | Rule of Nines | March-09 |
10.11 | Florida Statutes | March-09 |
10.12 | Evaluation and Treatment Flow Chart | March-09 |
10.13 | Spinal Injury Assessment Critical Criteria | March-09 |
10.14 | Celox Gauze Powerpoint | April-12 |
10.15 | Sepsis and Venous Lactate Powerpoint | April-12 |
10.16 | LVAD EMS Guide | Sept-18 |
10.16.1 | HeartMate III LVAD - Green | Sept-18 |
10.16.2 | HeartMate II LVAD - Red | Sept-18 |
10.16.3 | HeartWare LVAD - Dark Blue | Sept-18 |
10.16.4 | Jarvik 2000 LVAD - Lavendar | Sept-18 |
10.16.5 | Thoratec LVAD - Light Blue | Sept-18 |
10.16.6 | DuraHeart LVAD - Purple | Sept-18 |
10.16.7 | Total Artificial Heart LVAD - Pink | Sept-18 |
Section 11 - Medical Director Memos
Section 12 - Paramedic Clinical Assessment Program
Section | Description | Revision Date |
---|---|---|
12.01 | PCAP Guidelines | Jan-19 |
12.02 | ALS Contact Form | June-10 |
12.03 | Evaluation Form - Equip | Jan-13 |
12.04 | Evaluation Form - Protocols | Jan-13 |
12.05 | ALS Contact Definition | June-10 |
12.06 | Daily Performance Eval | Sept-17 |
12.07 | MD Meetings Roster | May-13 |
12.08 | Mentor Evaluation | May-13 |
12.09 | Verification of EMT Skills | May-13 |
12.10 | PCAP Completion Checklist | Sept-17 |
12.11 | Verification of Paramedic Skills | May-13 |
12.12 | ALS Contact Form Example 1 | Dec-14 |
12.13 | ALS Contact Form Example 2 | Dec-14 |
12.14 | Incapacitated Patient Management | Dec-14 |
Section 13 - COVID-19
Section | Description | Revision Date |
---|---|---|
13.01 | MD Memo - Please use Common Sense | 2020-03-13 |
13.02 | Hospital Screening and Procedures | 2020-03-26 |
13.03 | Dispatch Screening and Procedures | 2020-04-01 |
13.04 | Strict Respiratory Precautions Question Card | 2020-04-01 |
13.05 | American Red Cross Changed Response Procedures | 2020-03-31 |
13.06 | Clearance of COVID Positive, symptomatic and or exposed individuals from our previous advice | 2020-07-15 |
13.07 | Updated COVID Transport to FSED | 2020-07-20 |